Zhong, R., Yan, M., Wang, Q., Hong, H., Zhang, Y., Hu, M., Lan, Q., Luo, Y., Zhang, L., Wen, J., Xu, H., Guo, W., Lu, H., Guo, S., Zhang, L., Wu, L., Ma, J., Li, X., Huang, Y., Zhong, H. (2025). Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.107